Skip to content

Biogen BIIB Total Liabilities

Total Liabilities at other companies

TG Therapeutics logo
TG TherapeuticsTGTX
$945.71M+125%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$357.16M-2.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$431.05M+1.3%
Regenxbio logo
RegenxbioRGNX
$320.81M+48.0%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$48.76M-1.4%
Scholar Rock logo
Scholar RockSRRK
$259.24M+172%

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$30.36B+66.6%
Enterprise value$36.63B+66.1%
P/E34.4×+22.5×
P/S+1.2×

Profitability

See full
Gross margin74%-1.4pp
Operating margin22.9%
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.

The official record: Biogen’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's total liabilities?
Biogen (BIIB) reported total liabilities of $300.1M in Q2 2026.
How has Biogen's total liabilities changed year-over-year?
Biogen's total liabilities decreased by 97.2% year-over-year, from $10.7B to $300.1M.
What is the long-term trend for Biogen's total liabilities?
Over 5 years (2020 to 2025), Biogen's total liabilities has grown at a -53.4% compound annual growth rate (CAGR), from $13.93B to $305.3M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.